Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 20, 2022 | Seed | €2M | 2 | DSM Venturing Oskare Capital | — | Detail |
Mar 11, 2021 | Seed | $1.20M | 2 | Oskare Capital Vaekstfonden | — | Detail |
Nov 12, 2020 | Seed | $1.80M | 4 | Vaekstfonden | — | Detail |
Oct 21, 2020 | Non-Equity Assistant | — | 1 | MassChallenge | — | Detail |
Jan 13, 2020 | Pre-seed | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
DSM Venturing | Yes | Seed |
Oskare Capital | Yes | Seed |
Vaekstfonden | Yes | Seed |
MassChallenge | Yes | Non-Equity Assistant |
Bruce Linton | — | Seed |
Enexis AB | — | Seed |